Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023 GBD 2023 MASLD Collaborators ++...

Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023 GBD 2023 MASLD Collaborators https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00011-7/abstract?utm_campaign=gbdalerts&utm_medium=email&dgcid=hubspot_email_lancet-gbdalerts&_hsenc=p2ANqtz--BccPj2PjA-nWY_M_CHf5_7oA9XO13TytZTAQYGaXKLYSkKhfMR4AvQoqC4VuOxANJ4Ej5PWHPHVGyP8fOaMjcwgN6qg&_hsmi=423546589&utm_content=423510151&utm_source=hs_email Editorial p437 Confronting the global burden of MASLD The Lancet Gastroenterology & Hepatology https://www.thelancet.com/journals/langas/issue/vol11no6/PIIS2468-1253(26)X2004-0